AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology

Cited by (661)

Items 401–500 of 661

1. Benefits of inpatient initiation of β-blockers
   Héctor O. Ventura · 2004 · American Heart Journal
2. Use of Antithrombotic Agents Among U.S. Stroke Survivors, 2000–2006
   Eric M. Cheng, Stanley N. Cohen, Martin L. Lee, Stefanie D. Vassar, Alex Y. Chen · 2009 · American Journal of Preventive Medicine
3. The Lucent-Takes-Heart Cardiovascular Health Management Program
   Christine J. Guico‐Pabia, Laura Cioffi, Lawrence G. Shoner · 2002 · AAOHN Journal
4. Role of in-hospital initiation of carvedilol to improve treatment rates and clinical outcomes
   Gregg C. Fonarow · 2004 · The American Journal of Cardiology
5. The antichlamydial effects of drugs used in cardiovascular diseases
   Ying Yan · 2009
6. Standard Outcome Metrics and Evaluation Methodology for Disease Management Programs
   2003 · Disease Management
7. Machine learning framework for atherosclerotic cardiovascular disease risk assessment
   Parya Esmaeili, Neda Roshanravan, Saeid Mousavi, Samad Ghaffari, Naimeh Mesri Alamdari, Mohammad Asghari Jafarabadi · 2022 · Journal of Diabetes & Metabolic Disorders
8. Polyvascular Disease Influences Long-Term Cardiovascular Morbidity in Carotid Endarterectomy
   Lourenço Thierstein, Juliana Pereira-Macedo, Luís Gamas, Pedro Reis, Piotr Myrcha, José Paulo Andrade, João P. Rocha-Neves · 2023 · Annals of Vascular Surgery
9. Preventive fraction of physical fitness on risk factors in cardiac patients: Retrospective epidemiological study
   Maxime Caru, Laurence Kern, Marc Bousquet, Daniel Y. Curnier · 2018 · World Journal of Cardiology
10. Weight Change in Patients Attempting to Quit Smoking Post-myocardial Infarction
    Sonia Marzia Grandi, Kristian B. Filion, André Gervais, Lawrence Joseph, Jennifer L O’Loughlin, Gilles Paradis, Stéphane Rinfret, Louise Pilote, François R. Grondin, Sohrab R. Lutchmedial et al. · 2014 · The American Journal of Medicine
11. Strategies for establishing policy, environmental, and systems-level interventions for managing high blood pressure and high cholesterol in health care settings: a qualitative case study.
    Dyann Matson Koffman, Sharon A Granade, Victoria V. Anwuri · 2008 · PubMed Central
12. Reappraisal of β-blocker therapy in the acute and chronic post–myocardial infarction period
    Franceso Borrello, Maribeth Beahan, Liviu Klein, Mihai Gheorghiade · 2004 · The American Journal of Cardiology
13. Treating to goal: new strategies for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis
    Gregg C. Fonarow · 2002 · Vascular Medicine
14. Management of intermittent claudication.
    R. Brook, A. Weder, P.Michael Grossman, S. Rajagopalan · 2002 · Cardiology Clinics
15. 33rd Bethesda Conference: Preventive Cardiology: How Can We Do Better?*
    Philip A. Ades, Cory V. Noel, Bairey Merz, Gary John Balady, Emelia J. Benjamin, W. David Bradford, Richard Cooper, Jacqueline M. Dunbar‐Jacob, Gerald F. Fletcher, Michael D. Hill · 2002
16. Use of Antihypertensive Drug Therapy in Older Persons in an Academic Nursing Home
    Valerie Ziesmer, Subrata Ghosh, Wilbert S. Aronow · 2002 · Journal of the American Medical Directors Association
17. Policy and environmental indicators for heart disease and stroke prevention: data sources in two states.
    Delores M. Pluto, Martha M. Phillips, Dyann M. Matson-Koffman, Dennis Shepard, James M. Raczynski, J. Nell Brownstein · 2004 · Europe PMC (PubMed Central)
18. Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices.
    Mary Norine Walsh, Ross J. Simpson, George J. Wan, Thomas W Weiss, Charles M. Alexander, Leona Enama Markson, Marc L. Berger, Thomas A. Pearson · 2002 · PubMed
19. Secondary prevention in coronary artery disease patients in South Auckland: moving targets and the current treatment gap.
    Seifeddin S. El‐Jack, Andrew Kerr · 2003 · PubMed
20. Hierarchical Random Forest Formation with Nonlinear Regression Model for Cardiovascular Diseases Prediction
    Mohamed Aslam, K. Jaisharma · 2021 · International Conference on Computer Communication and Informatics (ICCCI)
21. Kritische Extremitätenischämie
    C. Denzel, W. Lang · 2008 · Der Chirurg
22. Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting
    Dimas Ikeoka, Carolina Z. Vieira, Pedro A. Lemos, Tânia Mara Varejão Strabelli, Expedito E. Ribeiro da Silva, Marco Antonio Perin, Andrea Groselj‐Strele, Beate Tiran, Andreas Tiran, Bruno Caramelli · 2008 · Clinical Research in Cardiology
23. Perioperative Use of β-Blockers in the Elderly Patient
    Stefan A. Lombaard, Reinette Robbertze · 2009 · Anesthesiology Clinics
24. Disparities in Combination Drug Therapy Use in Older Adults with Coronary Heart Disease
    Jennifer Tjia, Becky A. Briesacher, Dawei Xie, Jason Fu, Robert Joel Goldberg · 2010 · Drugs & Aging
25. Effect of Dementia on the Use of Drugs for Secondary Prevention of Ischemic Heart Disease
    Nicole R. Fowler, Amber E. Barnato, Howard B. Degenholtz, Angela M. Curcio, James T. Becker, Lewis H. Kuller, Oscar L. López · 2014 · Journal of Aging Research
26. Clopidogrel Provides Significantly Greater Inhibition of Platelet Activity Than Aspirin When Combined With Atorvastatin After Coronary Artery Bypass Grafting: A Prospective Randomized Study
    Şermin Tetik, Koray Ak, Selim İşbir, Emel Ekşioğlu, Sinan Arsan, Omer Iqbal, Turay Yardımcı · 2009 · Clinical and Applied Thrombosis/Hemostasis
27. Statin use in American Indians and Alaska Natives with coronary artery disease
    Catherine E. Cooke, James L. Bresette, Rozina Khanna · 2006 · American Journal of Health-System Pharmacy
28. The Lowering of Vascular Atherosclerotic Risk (LOVAR) Program: An Approach to Modifying Cerebral, Cardiac, and Peripheral Vascular Disease
    John Castaldo, JAMES F. REED · 2008 · Journal of Stroke and Cerebrovascular Diseases
29. Increased Adherence to Cardiac Standards of Care during Participation in Cardiac Disease Management Programs
    Carter R. Coberley, Greg Morrow, Matthew A. McGinnis, Aaron R. Wells, Sadie S. Coberley, Patty Montgomery Orr, Dexter W. Shurney · 2008 · Disease Management
30. The Utility of Dobutamine Stress Echocardiography for Perioperative and Long-term Cardiac Risk Assessment
    Miklos David Kertai, Don Poldermans · 2005 · Journal of Cardiothoracic and Vascular Anesthesia
31. Peripheral Arterial Disease
    Adam deJong · 2010 · ACSMʼs Health & Fitness Journal
32. Can the premises of the spasm of resistance vessel concept permit improvement in the treatment and prevention of ischemic heart disease?
    H. Richard Hellstrom · 2002 · Medical Hypotheses
33. Human Health Effects of Particulate Matter
    Manisha Saini, Monika Joon, Sunil Kumar Saini · 2022 · Springer eBooks
34. In-hospital Initiation of Cardiovascular Protective Therapies to Improve Treatment Rates and Clinical Outcomes
    Gregg C. Fonarow, Anna Gawlinski, Karol E. Watson · 2003 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
35. Management of Cardiometabolic Syndrome in the Primary and Secondary Prevention of Cardiovascular Disease
    M. D. Ashen · 2008 · The Journal for Nurse Practitioners
36. Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs
    Marjorie L. King, Mark A. Williams, Gerald F. Fletcher, Neil F. Gordon, Meg Gulanick, Carl N. King, Arthur S. Leon, Benjamin D. Levine, Fernando Costa, NANETTE KASS WENGER · 2005 · Journal of Cardiopulmonary Rehabilitation
37. Effect of depression on health behavior among myocardial infarction survivors in the United States
    Brooke A. Nicholson, Shawn Morse, T. Lundgren, Nina Vadiei, Sandipan Bhattacharjee · 2020 · Mental Health Clinician
38. Underuse of cardioprotective medications in patients prior to acute myocardial infarction
    Rosalie R. Miller, Yu-Fang Li, Haili Sun, Branko Kopjar, Anne E. Sales, Sandra L. Piñeros, Stephan D. Fihn · 2003 · The American Journal of Cardiology
39. How Optimal is the Medical Management of Patients Prior to Major Reconstructive Vascular Surgery? The Results of a Cross-sectional Study
    Christy L. Marshall, Peter H. Lin, Tam T. Huynh, Panagiotis Kougias · 2009 · Vascular and Endovascular Surgery
40. Evaluation of aspirin resistance and the presence of unstable carotid plaque in patients undergoing carotid endarterectomy
    Adam Lewszuk, Marek A Postula, Grzegorz Madycki, Walerian Staszkiewicz, Grzegorz Opolski, Andrzej Eberhardt · 2015 · Kardiologia Polska
41. Menopausal Hormone Therapy
    NANETTE KASS WENGER · 2004 · Humana Press eBooks
42. Persistence and Discontinuation of Oral Anticoagulant: Remaining Issues Not Addressed by Phase III Clinical Trials
    Kengo Ayabe, Shinichi Goto, Shinya Goto · 2016 · Journal of the American Heart Association
43. Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital.
    Thomas C. Bailey, Laura A Noirot, Brian F. Gage, Xia Li, William D. Shannon, Brian M. Waterman, Stuti Sinha, Dennis A Bouselli, Richard M. Reichley, Anne Carol Goldberg et al. · 2006 · Europe PMC (PubMed Central)
44. Review of current smoking cessation guidelines
    Christina Gratziou · 2008 · European Respiratory Society eBooks
45. Targeting Obesity to Optimize Weight Loss in Cardiac Rehabilitation
    Tina E. Brinkley, Fang‐Chi Hsu, Benita M. Bowman, Theresa Addison, Dalane W. Kitzman, Denise K. Houston · 2022 · Journal of Cardiopulmonary Rehabilitation and Prevention
46. Putting prevention into daily practice
    Jeff P. Steinhoff, Sidney C. Smith · 2003 · Cardiology Clinics
47. Diabetes Mellitus and Cardiovascular Disease in the Elderly
    Gabriel Gregoratos, Gordon Leung · 2008 · Fundamental and clinical cardiology
48. Physical Exercise in Chronic Diseases
    Bente Klarlund Pedersen · 2018 · Elsevier eBooks
49. Cardiac dual-source CT for the preoperative assessment of patients undergoing bariatric surgery
    Alessia Tognolini, Cesar Arellano, Wanda C. Marfori, James William Sayre, Jacqueline Hollada, Jonathan Gerald Goldin, Erik Dutson, Stefan G. Ruehm · 2012 · Clinical Radiology
50. NHG-Standaard Beleid na een doorgemaakt myocardinfarct
    H. G. L. M. Grundmeijer, STB Van Bentum, Frans Hendrik Rutten, J. Carel Bakx, J.M.A. Hendrick, Margriet Bouma, W H Eizenga, MM Verduijn · 2009 · Bohn Stafleu van Loghum eBooks
51. ASHP Therapeutic Position Statement on the Daily Use of Aspirin for Preventing Cardiovascular Events
    Joseph J. Saseen · 2005 · American Journal of Health-System Pharmacy
52. Recent advances in the secondary prevention of coronary heart disease
    Angie Veverka, Jamie L Jolly · 2004 · Expert Review of Cardiovascular Therapy
53. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: Randomized and observational comparisons of secondary prevention trials and their meta-analysis
    Charles H. Hennekens, Frank M. Sacks, Andrew Maxwell Tonkin, J. Wouter Jukema, Robert P. Byington, Bertram Pitt, Donald A. Berry, Scott M. Berry, Neville F. Ford, Andrew J. Walker et al. · 2003 · Journal of the American College of Cardiology
54. Routine statin treatment after acute coronary syndromes?
    Mónica Acevedo B, Dennis L. Sprecher, Michael S. Lauer, Gary S. Francis · 2002 · American Heart Journal
55. Bewegungstherapie bei koronarer Herzkrankheit
    David Niederseer, Josef Niebauer · 2010 · Springer eBooks
56. Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation
    Mojgan Hajahmadi Pourrafsanjani, Ebrahim Khayati Shal, Sina Khezrpour · 2019 · High Blood Pressure & Cardiovascular Prevention
57. A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk
    Giorgio Iervasi, Daniele Franchi · 2011 · Therapeutics and Clinical Risk Management
58. NonST-Elevation Myocardial Infarction) (Writing Committee to Develop Performance Measures for ST-Elevation and Cardiology/American Heart Association Task Force on Performance Measures NonST-Elevation Myocardial Infarction. A Report of the American College of ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and
    Arman Masoudi, Brahmajee K. Nallamothu, Stephan D. Fihn, JoAnne Micale Foody, P. Michael Ho, Mikhail Kosiborod, Marian M. Krumholz, Jeffrey L. Anderson, Brian L. Bachelder, Francis M. Fesmire · 2008
59. ME Cares: A Statewide System Engaging Providers in Disease Management
    Richard Wexler, Claudette Bean, Diane Ito, Zoe S. Kopp, John A. LaCasse, Vicki Rea · 2004 · Disease Management
60. Mortalidad y cumplimiento de los objetivos de prevención secundaria de la cardiopatía isquémica en pacientes ≥ 70 años: estudio observacional
    Elisenda Marcos-Forniol, Emili Corbella, Xavier Pintó · 2019 · Medicina Clínica
61. Auditing secondary prevention of ischaemic heart disease in rural areas of Spain: An opportunity for improvement
    José M. Turón, Julián Librero, Gabriel J. Díaz Grávalos, Juan J. García, Carme Beltral, Francisco Abal, ON BEHALF OF THE REDIMER STUDY GROU · 2006 · European Journal of General Practice
62. Primary care nursing of coronary patients and reduction of re-infarction risk: a nested case–control study
    Manuel Serrano-Martínez, B. Sanjulián-Aranguren, I. Ezpeleta-Iturralde, E. Madoz-Zubillaga, M.J. Urbina Goñi, Jokin de Irala · 2004 · Public Health
63. Acute Coronary Syndromes Clinical Practice Guidelines
    Ralph G. Brindis, E Fischer, Gary M Besinque, Alan Gjedsted, Philip C. Lee, Tom Padgett, Michael A. Petru, Jenni Raley, Eleanor G. Levin, Anita Strohmeier · 2006 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
64. The HEDIS® Performance NAVIGATOR for Controlling High Blood Pressure: A Resource to Assist Health Plans Improve Patient Adherence
    Robin S. Turpin, K Jungkind, Lucille AC Salvucci · 2003 · Disease Management
65. The effects of diet and orlistat on body weight and lipid profiles in high risk Chinese patients with coronary artery disease, obesity and hypercholesterolemia
    K. W. Chan, Wai-Shing Leung, Y. S. Fung, H. F. Hung, P. Tsui, H. Chu, Y. W. Chan, Gary T.C. Ko, Ming Wai Yeung · 2009 · Irish Journal of Medical Science (1971 -)
66. Hurricanes and heart failure: A review of the who, what, when, and where of beta-blocker therapy
    Kathy A. Hebert, Lee M. Arcement, Ron Horswell · 2006 · Current Heart Failure Reports
67. Starting early to control all risk factors in order to prevent coronary heart disease
    Henry C. McGill, Clyde Alex McMahan · 2010 · Clinical Lipidology
68. Appropriate Use of Exercise Testing Prior to Administration of Drugs for Treatment of Erectile Dysfunction
    Adelaide Maria Arruda-Olson, Patricia A. Pellikka · 2003 · Herz
69. Insulin Resistance as a Predictor of the Late Catch-up Phenomenon After Drug-Eluting Stent Implantation
    Takaaki Komatsu, Sachiko Komatsu, Hidehiko Nakamura, Takanori Kuroyanagi, Akinori Fujikake, Itaru Hisauchi, Masashi Sakuma, Shiro Nakahara, Yoshihiko Sakai, Isao Taguchi · 2016 · Circulation Journal
70. Effect of Kinesio Taping Application on Balance and Gait Ability in Hemiplegic Disables after Cerebral Stroke
    송명환, 조창옥, 전범수, 장지훈 · 2008 · 한국특수체육학회지
71. Inercia terapéutica en prevención secundaria de enfermedad cardiovascular
    Leonor Roa Santervas · 2014 · Dialnet (Universidad de la Rioja)
72. Von der kardialen Rehabilitation zur Prävention
    Hugo E. Saner · 2003 · Wiener klinische Wochenschrift
73. Optimal Treatment of Hypertension and Cardiovascular Risk Reduction in African Americans: Treatment Approaches for Outpatients
    Jackson T. Wright, Janice G. Douglas · 2003 · Journal of Clinical Hypertension
74. Management of the Patient Who Has Been Resuscitated From Sudden Cardiac Death
    David J. Callans · 2002 · Circulation
75. Left atrial thrombus, transient ischemic attack, and atrial fibrillation: Does left atrial thrombus predict? Does absence protect?
    Richard G. Sheahan · 2003 · American Heart Journal
76. ASPIRIN INDUCED CHANGES IN SERUM ACP, ALP, GOT, GPT, BILIRUBIN AND CREATININE IN CORELATION WITH HISTOPATHOLOGICAL CHANGES IN LIVER AND KIDNEY OF FEMALE ALBINO RAT Research Article
    Neha Jain, Renu Shrivastava, Arun K Raghuwanshi, Vinoy K. Shrivastava · 2012
77. Effectiveness of combined and conventional exercise trainings on the biochemical responses of stroke patients
    Isaac Kwaku Acheampong, Monday Omoniyi Moses, Biggie Baffour-Awuah, Ebenezer Essaw, Winifred Mensah, Daniel Afrifa, Lemuel Owusu · 2018 · Journal of Exercise Rehabilitation
78. Multicenter Study of Temporal Trends in the Achievement of Atherosclerotic Cardiovascular Disease Risk Factor Goals During Cardiac Rehabilitation
    Neil F. Gordon, Richard D. Salmon, Laurence S. Sperling, Brenda S. Wright, George C. Faircloth, Terri L. Gordon, Martin R. Berk, Melvyn Rubenfire, Barry A. Franklin · 2016 · Journal of Cardiopulmonary Rehabilitation and Prevention
79. Office Management after Myocardial Infarction
    Wilbert S. Aronow · 2010 · The American Journal of Medicine
80. Improving quality of care in vascular surgery: the tools are available now
    Peter K. Henke · 2005 · The American Journal of Surgery
81. Chronic stable angina: Addressing the needs of patients through risk reduction, education and support
    Kathy A. Berra, Barbara Johnston Fletcher, Nancy Houston Miller · 2008 · Clinical and investigative medicine
82. Clinically Classified Periodontitis and Its Association in Patients with Preexisting Coronary Heart Disease
    Nikolaos Andreas Chrysanthakopoulos, Panagiotis Andreas Chrysanthakopoulos · 2013 · Journal of Oral Diseases
83. Cardiovascular Risk Factors in the Elderly
    Susan J. Zieman, Beth R. Malasky · 2005 · Humana Press eBooks
84. Potential Antiatherosclerotic Drugs: Novel N-Substituted Taurinamide Derivatives
    Н. С. Сапронов, Khnychenko Lk, И. В. Окуневич, Ludmila K. Gavrovskaya · 2006 · Springer eBooks
85. Lower Extremity Arterial Disease
    John V. White · 2010 · Elsevier eBooks
86. Cardiovascular Disease
    Peter Paul Toth, Nicolas W. Shammas, Eric J. Dippel, Blair W. Foreman · 2012 · Elsevier eBooks
87. Sildenafil and Physical Exertion in Men With Coronary Artery Disease
    Robert F. DeBusk · 2002 · JAMA
88. PUTTING PREVENTION INTO DAILY PRACTICE
    Sidney C. Smith · 2000 · Medical Clinics of North America
89. Current approaches to patients with acute coronary syndromes
    Dolores M. Cortez · 2002 · Current Problems in Cardiology
90. Aggressive treatment of atherosclerosis: the time is now.
    Gregg C. Fonarow · 2003 · Cleveland Clinic Journal of Medicine
91. Physical activity, physical function and quality of life in community-based maintenance cardiac rehabilitation
    Garrick Hately, Sandra Mandic · 2019 · Health Education Journal
92. Severe Left Ventricular Systolic Dysfunction is Independently Associated with High On-Clopidogrel Platelet Reactivity
    Zuzana J Motovska, Martina Ondrakova, Magdalena Doktorova, Petr Widimský · 2014 · American Journal of Cardiovascular Drugs
93. Does Motor Dysfunction After Cerebral Infarction Impede the Development of Angina Symptoms?
    Hisataka Sasao, Hidetoshi Fujiwara, Hiroshi Murai, Tadakazu Shimizu, Haruhiko Hotta, Naruyoshi Horiuchi, Hitoshi Okumura, Hiroshi Abe, Yasumichi TANAKA · 2013 · International Heart Journal
94. Age and Gender Biases in Secondary??Prevention of Coronary??Heart Disease in a Finnish??University Hospital Setting
    Sanna-Maria Michou, Mika A. P. Kähönen, Terho J. Lehtimäki, Kjell Christer Nikus, Jari Viik, K. Niemel�, Janne Kallio, Rami Lehtinen, Tiit K bi, Väinö Turjanmaa et al. · 2007 · Clinical Drug Investigation
95. Effectiveness of Interventions to Increase Adherence to Statin Therapy
    Jacqueline M ller-Nordhorn, Stefan N. Willich · 2005 · Disease Management & Health Outcomes
96. Rehabilitation (EACPR) Developed with the special contribution of the European Association for Cardiovascular Prevention & Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) : The Fifth
    Christiaan J. Vrints, David Wood, José Luis Zamorano, Faiez M. Zannad, Şehnaz Karadeniz, Alessandro Mezzani, Eva Prescott, Shah B J Ebrahim, Giuseppe Germanò, Richard F. Hobbs et al. · 2013
97. Endothelial nitric oxide synthase gene -922A>G, -786 T>C, 4b/4a, and 894 G>T variants and premature coronary artery disease: An association study with haplotype analysis
    Amirsaeed Sabeti Aghabozorgi, Hossein Farshidi, Zahra Farbood, Najmeh Ahangari, Tasnim Eghbal Eftekhaari, Amirhossein Bahreyni, Azim Nejatizadeh · 2018 · Meta Gene
98. Rehabilitation Modalities
    Pantaleo Giannuzzi · 2007 · Springer eBooks
99. ST-Elevation Myocardial Infarction
    Eric Bates, Frederick G. Kushner · 2007 · Elsevier eBooks
100. Obesity and the Heart
     Alison Morris, Paul Poirier, Robert H. Eckel · 2007 · Humana Press eBooks